7478-26-4Relevant articles and documents
Coupling of a competitive and an irreversible ligand generates mixed type inhibitors of Trypanosoma cruzi trypanothione reductase
Inhoff, Oliver,Richards, Jonathan M.,Br?et, Jan Willem,Lowe, Gordon,Krauth-Siegel, R. Luise
, p. 4524 - 4530 (2002)
9-Aminoacridines and (terpyridine)platinum(II) complexes are competitive and irreversible inhibitors, respectively, of trypanothione reductase from Trypanosoma cruzi, the causative agent of Chagas' disease. Four chimeric compounds in which 2-methoxy-6-chl
Synthesis of monomeric and dimeric acridine compounds as potential therapeutics in Alzheimer and prion diseases
Csuk, Rene,Barthel, Alexander,Raschke, Christian,Kluge, Ralph,Stroehl, Dieter,Trieschmann, Lothar,Boehm, Gerald
experimental part, p. 699 - 709 (2010/06/19)
Starting from substituted 9-chloroacridines, a series of quinacrine and spacered dimeric acridine compounds was prepared. Their ability to interrupt the protein association of prion- and Alzheimer-specific proteins and Ab peptides was explored using a fast screening system based on FACS analysis. The bis-acridines displayed a higher activity than the corresponding monomers. Among these derivatives, best results were obtained with the 2,4-dimethoxy-6-nitro compound 7h for Aβ-peptides and the 2-methoxy-6-nitro compound 7f for PrP.
Synthesis and antiproliferative activity of some variously substituted acridine and azacridine derivatives
Ferlin, Maria Grazia,Marzano, Cristina,Chiarelotto, Gianfranco,Baccichetti, Francarosa,Bordin, Franco
, p. 827 - 837 (2007/10/03)
A group of 9-substituted acridine and azacridine derivatives (m-AMSA analogues) were synthesised following classical procedures as potential antitumour agents with inhibitory effects on DNA topoisomerase II. Some were found to have noticeable cytotoxicity against human HL-60 and HeLa cells grown in culture. Their non-covalent interactions with calf thymus DNA have been studied using fluorescence quenching. We evaluated DNA damage produced by the tested compounds by means of DNA filter elution and protein precipitation techniques. Catalytic studies carried out with purified topoisomerase confirmed these agents as antitopoisomerase inhibitors. Chemotherapy of solid-tumour-bearing mice with tested compounds allowed an aza-analogue (compound IIIb), as potent as m-AMSA but less toxic towards the host, to be recognised. (C) 2000 Editions scientifiques et medicales Elsevier SAS.